ARTICLE | Company News
Cellcentric, ZoBio deal
June 25, 2012 7:00 AM UTC
CellCentric and ZoBio partnered to develop compounds against epigenetic drug targets for primarily oncology indications along with other therapeutic areas. ZoBio will use its Target Immobilized NMR Sc...